Fowler, Paul Alfred Francois

Harris, William Joseph

Mason, H D

Sorsa-Leslie, Tarja Kristina

Reproductive Biology and Endocrinology

English

PubMed

Springer - Publisher Connector

Selection of gonadotrophin surge attenuating factor phage antibodies by bioassay

The Open University

A: Higher gonadotrophin surge-attenuating factor bioactivity is found in small follicles from superovulated women.

A: The nature and function of putative gonadotropin surge-attenuating/inhibiting factor (GnSAF/ IF). Endocr Rev

AJ: Detection and quantification of microcystins (cyanobacterial hepatotoxins) with recombinant antibody fragments isolated from a naive human phage display library. FEMS Microbiol Lett

AJ: Rapid selection of anti-hapten antibodies isolated from synthetic and semi-synthetic antibody phage display libraries expressed in Escherichia coli.

Cheng CY: Purification of a candidate gonadotropin surge inhibiting factor from porcine follicular fluid. Endocrinology

Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry. Nature

H: A proteomic analysis of erythromycin resistance in Streptococcus pneumoniae. Electrophoresis

Harris WJ: Escherichia coli skp chaperone coexpression improves solubility and phage display of single-chain antibody fragments. Protein Expr Purif

HD: Ovarian gonadotrophin surge-attenuating factor (GnSAF): where are we after 20 years of research? Reproduction

HD: Relationship between follicle size and gonadotrophin surge attenuating factor (GnSAF) bioactivity during spontaneous cycles in women. Hum Reprod

Horwitz AH: Escherichia coli secretion of an active chimeric antibody fragment. Science

Human SAD1 kinase is involved in UV-induced DNA damage checkpoint function.

JD: Towards proteome-wide production of monoclonal antibody by phage display.

JS: Development of a Haemophilus two-dimensional protein database. Electrophoresis

Laoudj D: Identification of new proteins in follicular fluid of mature human follicles. Electrophoresis

Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem

Messinis IE: Changes in pituitary sensitivity to GnRH in estrogen-treated post-menopausal women: evidence that gonadotrophin surge attenuating factor plays a physiological role. Hum Reprod

Messinis IE: Purification of a candidate gonadotrophin surge attenuating factor from human follicular fluid. Hum Reprod

Nieschlag E: Isolation of a protein from human ovarian follicular fluid which exerts major stimulatory effects on in vitro steroid production of testicular, ovarian, and adrenal cells. Endocrinology

Proteolytic selection for protein folding using filamentous bacteriophages. Fold Des

Purification of gonadotropin surge-inhibiting factor from Sertoli cell-enriched culture medium.

RI: The LZT proteins; the LIV-1 subfamily of zinc transporters. Biochim Biophys Acta

Rommerts FF: The stimulatory effect of albumin on luteinizing hormone-stimulated Leydig cell steroid production depends on its fatty acid content and correlates with conformational changes. Mol Cell Endocrinol

Sample application by in-gel rehydration improves the resolution of two-dimensional electrophoresis with immobilized pH gradients in the first dimension. Electrophoresis

Seferiadis K: The recombinant subdomain IIIB of human serum albumin dis-

Spears N: The cultured rodent follicle as a model for investigations of gonadotrophin surge-attenuating factor (GnSAF) production. Reproduction

The recombinant subdomain IIIB of human serum albumin displays activity of gonadotrophin surge-attenuating factor. Hum Reprod

W: A 60-66 kDa protein with gonadotrophin surge attenuating factor bioactivity is produced by human ovarian granulosa cells. Mol Hum Reprod

WJ: Expression of monovalent and bivalent antibody fragments in Escherichia coli.

WJ: Separation and concentration of bacteria with immobilized antibody fragments.

WJ: Spontaneous assembly of bivalent single chain antibody fragments in Escherichia coli. Mol Immunol

Tarja Sorsa-Leslie

Helen D Mason

William J Harris

Paul A Fowler

Background: We aimed to combine the generation of "artificial" antibodies with a rat pituitary bioassay

as a new strategy to overcome 20 years of difficulties in the purification of gonadotrophin surgeattenuating

factor (GnSAF).



Methods: A synthetic single-chain antibody (Tomlinson J) phage display library was bio-panned with partially purified GnSAF produced by cultured human granulosa/luteal cells. The initial screening with a simple binding immunoassay resulted in 8 clones that were further screened using our in-vitro rat monolayer bioassay for GnSAF. Initially the antibodies were screened as pooled phage forms and subsequently as individual, soluble, single-chain antibody (scAbs) forms. Then, in order to improve the

stability of the scAbs for immunopurification purposes, and to widen the range of labelled secondary antibodies available, these were engineered into full-length human immunoglobulins. The immunoglobulin with the highest affinity for GnSAF and a previously described rat anti-GnSAF polyclonal antiserum was then used to immunopurify bioactive GnSAF protein. The two purified preparations were electrophoresed on 1-D gels and on 7 cm 2-D gels (pH 4–7). The candidate GnSAF protein bands and spots were then excised for peptide mass mapping.



Results: Three of the scAbs recognised GnSAF bioactivity and subsequently one clone of the purified scAb-derived immunoglobulin demonstrated high affinity for GnSAF bioactivity, also binding the molecule in such as way as to block its bioactivity. When used for repeated immunopurification cycles and then Western blot, this antibody enabled the isolation of a GnSAF-bioactive protein band at around 66 kDa. Similar results were achieved using the rat anti-GnSAF polyclonal antiserum. The main candidate molecules identified from the immunopurified material by excision of 2-D gel protein spots was human serum

albumin precursor and variants.



Conclusion: This study demonstrates that the combination of bioassay and phage display technologies is a powerful tool in the study of uncharacterised proteins that defy conventional approaches. In addition, we conclude that these data support suggestions that GnSAF may be structurally related to serum albumin or very tightly bound to serum albumin

Sorsa-Leslie, T

Mason, HD

Harris, WJ

Fowler, PA

St George's Online Research Archive

Abstract Background We aimed to combine the generation of "artificial" antibodies with a rat pituitary bioassay as a new strategy to overcome 20 years of difficulties in the purification of gonadotrophin surge-attenuating factor (GnSAF). Methods A synthetic single-chain antibody (Tomlinson J) phage display library was bio-panned with partially purified GnSAF produced by cultured human granulosa/luteal cells. The initial screening with a simple binding immunoassay resulted in 8 clones that were further screened using our in-vitro rat monolayer bioassay for GnSAF. Initially the antibodies were screened as pooled phage forms and subsequently as individual, soluble, single-chain antibody (scAbs) forms. Then, in order to improve the stability of the scAbs for immunopurification purposes, and to widen the range of labelled secondary antibodies available, these were engineered into full-length human immunoglobulins. The immunoglobulin with the highest affinity for GnSAF and a previously described rat anti-GnSAF polyclonal antiserum was then used to immunopurify bioactive GnSAF protein. The two purified preparations were electrophoresed on 1-D gels and on 7 cm 2-D gels (pH 4–7). The candidate GnSAF protein bands and spots were then excised for peptide mass mapping. Results Three of the scAbs recognised GnSAF bioactivity and subsequently one clone of the purified scAb-derived immunoglobulin demonstrated high affinity for GnSAF bioactivity, also binding the molecule in such as way as to block its bioactivity. When used for repeated immunopurification cycles and then Western blot, this antibody enabled the isolation of a GnSAF-bioactive protein band at around 66 kDa. Similar results were achieved using the rat anti-GnSAF polyclonal antiserum. The main candidate molecules identified from the immunopurified material by excision of 2-D gel protein spots was human serum albumin precursor and variants. Conclusion This study demonstrates that the combination of bioassay and phage display technologies is a powerful tool in the study of uncharacterised proteins that defy conventional approaches. In addition, we conclude that these data support suggestions that GnSAF may be structurally related to serum albumin or very tightly bound to serum albumin.</p

Mason Helen D

Sorsa-Leslie Tarja

Harris William J

Fowler Paul A

Directory of Open Access Journals

https://aura.abdn.ac.uk/bitstream/2164/1199/1/Sorsa-Leslie_Selection_of_gonadotrophin_surge_attenuating_factor_phage_antibodies_by_bioassay.pdf

Selection of gonadotrophin surge attenuating factor phage antibodies by bioassay

Abstract

Similar works

Full text

Available Versions

Springer - Publisher Connector

The Open University

Springer - Publisher Connector

St George's Online Research Archive

Directory of Open Access Journals